{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:47:03Z","timestamp":1789879623673,"version":"4.0.1"},"reference-count":47,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,3,28]]},"DOI":"10.18632\/oncotarget.15501","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T11:33:37Z","timestamp":1487763217000},"page":"21115-21127","source":"Crossref","is-referenced-by-count":14,"title":["Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition"],"prefix":"10.18632","volume":"8","author":[{"given":"Magdalena","family":"Mazurkiewicz","sequence":"first","affiliation":[{"name":"Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institute, S-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellin-Kristina","family":"Hillert","sequence":"additional","affiliation":[{"name":"Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institute, S-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Health Sciences (IMH), Link\u00f6ping University, S-751 85 Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Pellegrini","sequence":"additional","affiliation":[{"name":"Department of Medical Health Sciences (IMH), Link\u00f6ping University, S-751 85 Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria H\u00e4gg","family":"Olofsson","sequence":"additional","affiliation":[{"name":"Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institute, S-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Selvaraju","sequence":"additional","affiliation":[{"name":"Department of Medical Health Sciences (IMH), Link\u00f6ping University, S-751 85 Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padraig","family":"D\u2019Arcy","sequence":"additional","affiliation":[{"name":"Department of Medical Health Sciences (IMH), Link\u00f6ping University, S-751 85 Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig","family":"Linder","sequence":"additional","affiliation":[{"name":"Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institute, S-171 76 Stockholm, Sweden"},{"name":"Department of Medical Health Sciences (IMH), Link\u00f6ping University, S-751 85 Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,18]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4614-6176-0_15","article-title":"Genetic targets in pediatric acute lymphoblastic leukemia","volume":"779","author":"Dovat","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/bjh.13852","article-title":"Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia","volume":"172","author":"Irving","year":"2016","journal-title":"Br J Haematol"},{"key":"3","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Mullighan","year":"2013","journal-title":"Lancet"},{"key":"4","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1002\/cncr.29573","article-title":"Childhood acute lymphoblastic leukemia: Integrating genomics into therapy","volume":"121","author":"Hunger","year":"2015","journal-title":"Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cancergencyto.2003.09.003","article-title":"Prevalence of TEL\/AML1 fusion gene in Brazilian pediatric patients with acute lymphoblastic leukemia","volume":"151","author":"Paskulin","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Aster","year":"2004","journal-title":"Science"},{"key":"7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20072182","article-title":"Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia","volume":"205","author":"Sanchez","year":"2008","journal-title":"J Exp Med"},{"key":"8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Evans","year":"2006","journal-title":"N Engl J Med"},{"key":"9","first-page":"2619","article-title":"Inhibition of leukemias in man by L-asparaginase","volume":"27","author":"Kim","year":"1967","journal-title":"Cancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11764-013-0292-8","article-title":"Risk of subsequent malignancies in survivors of childhood leukemia","volume":"7","author":"Frangoul","year":"2013","journal-title":"J Cancer Surviv"},{"key":"11","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-06-2258","article-title":"Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition","volume":"67","author":"Voll","year":"2007","journal-title":"Cancer Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells","volume":"107","author":"Boise","year":"2006","journal-title":"Blood"},{"key":"13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.molcel.2012.08.003","article-title":"Failure of amino acid homeostasis causes cell death following proteasome inhibition","volume":"48","author":"Bertolotti","year":"2012","journal-title":"Mol Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.15252\/embj.201387076","article-title":"Survival of mycobacteria depends on proteasome-mediated amino acid recycling under nutrient limitation","volume":"33","author":"Gur","year":"2014","journal-title":"EMBO J"},{"key":"15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/17474086.2016.1216311","article-title":"The role of proteasome inhibition in the treatment of malignant and non-malignant hematologic disorders","volume":"9","author":"Teachey","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/pbc.21214","article-title":"Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program","volume":"50","author":"Smith","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood-2012-04-418640","article-title":"Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study","volume":"120","author":"Bostrom","year":"2012","journal-title":"Blood"},{"key":"18","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/nm.2536","article-title":"Inhibition of proteasome deubiquitinating activity as a new cancer therapy","volume":"17","author":"Linder","year":"2011","journal-title":"Nat Med"},{"key":"19","doi-asserted-by":"crossref","first-page":"26979","DOI":"10.1038\/srep26979","article-title":"The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells","volume":"6","author":"Linder","year":"2016","journal-title":"Sci Rep"},{"key":"20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1124\/mol.113.091322","article-title":"The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death","volume":"85","author":"Linder","year":"2014","journal-title":"Mol Pharmacol"},{"key":"21","article-title":"Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15","author":"Linder","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"22","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1089\/ars.2013.5322","article-title":"Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress","volume":"21","author":"Linder","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"23","doi-asserted-by":"crossref","first-page":"e108839","DOI":"10.1371\/journal.pone.0108839","article-title":"Elevation of proteasomal substrate levels sensitizes cells to apoptosis induced by inhibition of proteasomal deubiquitinases","volume":"9","author":"Swanton","year":"2014","journal-title":"PloS One"},{"key":"24","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nmeth.2518","article-title":"Integrated proteomic analysis of post-translational modifications by serial enrichment","volume":"10","author":"Carr","year":"2013","journal-title":"Nat Methods"},{"key":"25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.molcel.2011.08.025","article-title":"Systematic and quantitative assessment of the ubiquitin-modified proteome","volume":"44","author":"Gygi","year":"2011","journal-title":"Mol Cell"},{"key":"26","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1093\/nar\/gkr424","article-title":"Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood","volume":"39","author":"Fredriksson","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/sj.bjc.6604003","article-title":"Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells","volume":"97","author":"Ohyashiki","year":"2007","journal-title":"Br J Cancer"},{"key":"28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2013-05-500033","article-title":"A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance","volume":"123","author":"Anderson","year":"2014","journal-title":"Blood"},{"key":"29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/bjh.13304","article-title":"Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenstrom macroglobulinaemia tumour cells","volume":"169","author":"Chanan-Khan","year":"2015","journal-title":"Br J Haematol"},{"key":"30","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1038\/bcj.2016.93","article-title":"Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells","volume":"6","author":"Edenfield","year":"2016","journal-title":"Blood Cancer Journal"},{"key":"31","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1128\/MCB.24.22.9695-9704.2004","article-title":"Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells","volume":"24","author":"Wang","year":"2004","journal-title":"Mol Cell Biol"},{"key":"32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1463-1326.2010.01281.x","article-title":"The unfolded protein response is required to maintain the integrity of the endoplasmic reticulum, prevent oxidative stress and preserve differentiation in beta-cells","volume":"12","author":"Hassler","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20121098","article-title":"Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR","volume":"449","author":"Mitchell","year":"2013","journal-title":"Biochem J"},{"key":"34","doi-asserted-by":"crossref","first-page":"E1124","DOI":"10.1152\/ajpendo.00080.2013","article-title":"The eukaryotic initiation factor 2 kinase GCN2 protects against hepatotoxicity during asparaginase treatment","volume":"305","author":"Anthony","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbior.2014.04.003","article-title":"Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles","volume":"55","author":"Proud","year":"2014","journal-title":"Adv Biol Regul"},{"key":"36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cellsig.2016.01.005","article-title":"Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy","volume":"28","author":"Proud","year":"2016","journal-title":"Cell Signal"},{"key":"37","doi-asserted-by":"crossref","first-page":"e00498","DOI":"10.7554\/eLife.00498","article-title":"Pharmacological brake-release of mRNA translation enhances cognitive memory","volume":"2","author":"Hann","year":"2013","journal-title":"ELife"},{"key":"38","first-page":"4","article-title":"The small molecule ISRIB reverses the effects of eIF2alpha phosphorylation on translation and stress granule assembly","author":"Walter","year":"2015","journal-title":"ELife"},{"key":"39","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1121925","article-title":"Protein synthesis upon acute nutrient restriction relies on proteasome function","volume":"310","author":"Hartl","year":"2005","journal-title":"Science"},{"key":"40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pedneo.2014.10.006","article-title":"Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance","volume":"56","author":"Chen","year":"2015","journal-title":"Pediatr Neonatol"},{"key":"41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","article-title":"A three-dimensional model to analyze drug-drug interactions","volume":"14","author":"Shipman","year":"1990","journal-title":"Antiviral Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000345260","article-title":"Recent advancements of bortezomib in acute lymphocytic leukemia treatment","volume":"129","author":"Chen","year":"2013","journal-title":"Acta Haematol"},{"key":"43","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-14-0568","article-title":"Molecular pathways: translational potential of deubiquitinases as drug targets","volume":"20","author":"Linder","year":"2014","journal-title":"Clin Cancer Res"},{"key":"44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrm2838","article-title":"The mechanism of eukaryotic translation initiation and principles of its regulation","volume":"11","author":"Pestova","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/toxins3050453","article-title":"Inhibition of the unfolded protein response by ricin a-chain enhances its cytotoxicity in mammalian cells","volume":"3","author":"Cohick","year":"2011","journal-title":"Toxins (Basel)"},{"key":"46","doi-asserted-by":"crossref","first-page":"12416","DOI":"10.1074\/jbc.M109.074211","article-title":"Chemotherapeutic drugs inhibit ribosome biogenesis at various levels","volume":"285","author":"Eick","year":"2010","journal-title":"J Biol Chem"},{"key":"47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1097-2765(00)80435-9","article-title":"Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination","volume":"5","author":"Clurman","year":"2000","journal-title":"Mol Cell"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T13:38:58Z","timestamp":1589117938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,18]]},"references-count":47,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017,3,28]]}},"alternative-id":["15501","28423502"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15501","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,18]]}}}